FDA Approves Arcutis' ZORYVE (Roflumilast) Cream 0.3% For The Treatment Of Plaque Psoriasis In Individuals Age 12 And Older

Press/Media

Period29 Jul 2022

Media coverage

1

Media coverage

  • TitleFDA Approves Arcutis' ZORYVE (Roflumilast) Cream 0.3% For The Treatment Of Plaque Psoriasis In Individuals Age 12 And Older
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date29/07/22
    PersonsMark Lebwohl
View all 1
View less